Pain Will Lead to Gain for Minnesota's Medical Cannabis Program

LeafLine MinnMedIn a hugely positive move that came against the official recommendation of its advisory board, the Minnesota Department of Health approved intractable pain as a qualifying condition in the state’s medical cannabis program.  Minnesotans have seen the new program struggle since the July 1st launch, with only 760 patients in the program, but the addition next August of what is the most common qualifying condition in other states by far has the potential to boost the program dramatically, which could benefit the two medical cannabis suppliers, LeafLine Labs and Minnesota Medical Solutions, which is owned by Vireo Health.

Read Grayson’s “Minnesota medical marijuana expansion for pain will boost program”:

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter